|
1
|
Rao R and Honavar SG: Retinoblastoma.
Indian J Pediatr. 84:937–944. 2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Steinmetz B, Hackl H, Slabáková E,
Schwarzinger I, Smějová M, Spittler A, Arbesu I, Shehata M, Souček
K and Wieser R: The oncogene EVI1 enhances transcriptional and
biological responses of human myeloid cells to all-trans retinoic
acid. Cell Cycle. 13:2931–2943. 2014.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Zhan XX, Liu Y, Yang JF, Wang GY, Mu L,
Zhang TS, Xie XL, Wang JH, Liu YM, Kong QF, et al:
All-trans-retinoic acid ameliorates experimental allergic
encephalomyelitis by affecting dendritic cell and monocyte
development. Immunology. 138:333–345. 2013.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Philippeit C, Busch M and Dünker N:
Epigenetic control of trefoil factor family (TFF) peptide
expression in human retinoblastoma cell lines. Cell Physiol
Biochem. 34:1001–1014. 2014.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Chawla B, Jain A and Azad R: Conservative
treatment modalities in retinoblastoma. Indian J Ophthalmol.
61:479–485. 2013.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Abramson DH, Shields CL, Munier FL and
Chantada GL: Treatment of retinoblastoma in 2015: Agreement and
disagreement. JAMA Ophthalmol. 133:1341–1347. 2015.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Varan A, Kiratli H, Aydın B, Tarlan B,
Poyraz CB, Akyüz C and Büyükpamukçu M: The treatment of
retinoblastoma with four-drug regimen including cisplatin,
etoposide, vincristine, and cyclophosphamide. Pediatr Hematol
Oncol. 29:529–537. 2012.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Chantada G and Schaiquevich P:
Intra-arterial Chemotherapy for Retinoblastoma. JAMA Ophthalmol.
134:1202–1203. 2016.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Lou Y, Qian W, Meng H, Mai W, Tong H, Tong
Y, Huang J and Jin J: High efficacy of arsenic trioxide plus
all-trans retinoic acid based induction and maintenance therapy in
newly diagnosed acute promyelocytic leukemia. Leuk Res. 37:37–42.
2013.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Masetti R, Vendemini F, Zama D, Biagi C,
Gasperini P and Pession A: All-trans retinoic acid in the treatment
of pediatric acute promyelocytic leukemia. Expert Rev Anticancer
Ther. 12:1191–1204. 2012.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Silverman JA and Deitcher SR:
Marqibo® (vincristine sulfate liposome injection)
improves the pharmacokinetics and pharmacodynamics of vincristine.
Cancer Chemother Pharmacol. 71:555–564. 2013.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Zhang H, Li B, Bai SW and Wang HJ:
Constitutively active Akt contributes to vincristine resistance in
human retinoblastoma cells. Cancer Invest. 28:156–165.
2010.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Ma X, Hu M, Wang H and Li J: Discovery of
traditional Chinese medicine monomers and their synthetic
intermediates, analogs or derivatives for battling P-gp-mediated
multi-drug resistance. Eur J Med Chem. 159:381–392. 2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Liu Y, Xu Y, Ji W, Li X, Sun B, Gao Q and
Su C: Anti-tumor activities of matrine and oxymatrine: Literature
review. Tumour Biol. 35:5111–5119. 2014.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Yang N, Han F, Cui H, Huang J, Wang T,
Zhou Y and Zhou J: Matrine suppresses proliferation and induces
apoptosis in human cholangiocarcinoma cells through suppression of
JAK2/STAT3 signaling. Pharmacol Rep. 67:388–393. 2015.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Chen J, Mei Q, Xu Y-C, Du J, Wei Y and Xu
Z-M: Effects of matrine injection on T-lymphocyte subsets of
patients with malignant tumor after gamma knife radiosurgery. J
Chin Integr Med. 4:78–79. 2006.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
17
|
Huang S, Fan W, Liu P and Tian J: Meta
analysis of compound matrine injection combined with cisplatin
chemotherapy for advanced gastric cancer. Zhongguo Zhong Yao Za
Zhi. 36(22):3198–202. 2011.PubMed/NCBI(In Chinese).
|
|
18
|
Zhang LP, Jiang JK, Tam JW, Zhang Y, Liu
XS, Xu XR, Liu BZ and He YJ: Effects of Matrine on proliferation
and differentiation in K-562 cells. Leuk Res. 25:793–800.
2001.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Jiang H, Hou C, Zhang S, Xie H, Zhou W,
Jin Q, Cheng X, Qian R and Zhang X: Matrine upregulates the cell
cycle protein E2F-1 and triggers apoptosis via the mitochondrial
pathway in K562 cells. Eur J Pharmacol. 559:98–108. 2007.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Li H, Tan G, Jiang X, Qiao H, Pan S, Jiang
H, Kanwar JR and Sun X: Therapeutic effects of matrine on primary
and metastatic breast cancer. Am J Chin Med. 38:1115–1130.
2010.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Liu T, Song Y, Chen H, Pan S and Sun X:
Matrine inhibits proliferation and induces apoptosis of pancreatic
cancer cells in vitro and in vivo. Biol Pharm Bull. 33:1740–1745.
2010.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Zhao B, Li B, Bai S, Shen L, Ren R, Jonas
JB, Xu X, Lu Q and Liu Q: Effects of matrine on proliferation and
apoptosis of cultured retinoblastoma cells. Graefes Arch Clin Exp
Ophthalmol. 250:897–905. 2012.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Wang XQ, Wang YC, Guo YT and Tang X:
Effect of piperlongumine on drug resistance reversal in human
retinoblastoma HXO-RB44/VCR and SO-Rb50/CBP cell lines. Int J Clin
Exp Pathol. 8:2525–2534. 2015.PubMed/NCBI
|
|
24
|
Shields CL, Ramasubramanian A, Thangappan
A, et al: Chemoreduction for group E retinoblastoma: comparison of
chemoreduction alone versus chemoreduction plus low-dose external
radiotherapy in 76 eyes. Ophthalmology. 116:544–551 e541.
2009.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Schueler AO, Anastassiou G, Jurklies C,
Havers W, Wieland R and Bornfeld N: De novo intraocular
retinoblastoma development after chemotherapy in patients with
hereditary retinoblastoma. Retina. 26:425–431. 2006.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Filho JP, Correa ZM, Odashiro AN, Coutinho
AB, Martins MC, Erwenne CM and Burnier MN Jr: Histopathological
features and P-glycoprotein expression in retinoblastoma. Invest
Ophthalmol Vis Sci. 46:3478–3483. 2005.PubMed/NCBI View Article : Google Scholar
|
|
27
|
O'Driscoll L, Walsh N, Larkin A, Ballot J,
Ooi WS, Gullo G, O'Connor R, Clynes M, Crown J and Kennedy S:
MDR1/P-glycoprotein and MRP-1 drug efflux pumps in pancreatic
carcinoma. Anticancer Res. 27 (4B):2115–2120. 2007.PubMed/NCBI
|
|
28
|
Xu X, Ling Q, Gao F, He ZL, Xie HY and
Zheng SS: Hepatoprotective effects of marine and kuhuang in liver
transplant recipients. Am J Chin Med. 37:27–34. 2009.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Zhang S, Qi J, Sun L, Cheng B, Pan S, Zhou
M and Sun X: Matrine induces programmed cell death and regulates
expression of relevant genes based on PCR array analysis in C6
glioma cells. Mol Biol Rep. 36:791–799. 2009.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Zhang Y, Zhang H, Yu P, Liu Q, Liu K, Duan
H, Luan G, Yagasaki K and Zhang G: Effects of matrine against the
growth of human lung cancer and hepatoma cells as well as lung
cancer cell migration. Cytotechnology. 59:191–200. 2009.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Qin X-G, Hua Z, Shuang W, Wang YH and Cui
YD: Effects of matrine on HepG2 cell proliferation and expression
of tumor relevant proteins in vitro. Pharm Biol. 48:275–281.
2010.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Li J, Yang S and Zhu G: Postnatal calpain
inhibition elicits cerebellar cell death and motor dysfunction.
Oncotarget. 8:87997–88007. 2017.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Li Q, Cheng H, Zhu G, Yang L, Zhou A, Wang
X, Fang N, Xia L, Su J, Wang M, et al: Gambogenic acid inhibits
proliferation of A549 cells through apoptosis-inducing and cell
cycle arresting. Biol Pharm Bull. 33:415–420. 2010.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Savill J and Fadok V: Corpse clearance
defines the meaning of cell death. Nature. 407:784–788.
2000.PubMed/NCBI View
Article : Google Scholar
|
|
35
|
Birkinshaw RW and Czabotar PE: The BCL-2
family of proteins and mitochondrial outer membrane
permeabilisation. Semin Cell Dev Biol. 72:152–162. 2017.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Opferman JT and Kothari A: Anti-apoptotic
BCL-2 family members in development. Cell Death Differ. 25:37–45.
2018.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Kim EM, Jung CH, Song JY, Park JK and Um
HD: Pro-apoptotic Bax promotes mesenchymal-epithelial transition by
binding to respiratory complex-I and antagonizing the malignant
actions of pro-survival Bcl-2 proteins. Cancer Lett. 424:127–135.
2018.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Diehl JA and Knudsen KE: Splice variants
and phosphorylated isoforms of cyclin D1 in tumorigenesis. In:
D-type Cyclins and Cancer. Hinds PW, Brown NE (eds). Springer,
Berlin, pp 91-109, 2018.
|
|
39
|
VanArsdale T, Boshoff C, Arndt KT and
Abraham RT: Molecular pathways: Targeting the cyclin D-CDK4/6 axis
for cancer treatment. Clin Cancer Res. 21:2905–2910.
2015.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Shao Q, Zhao X and Yao L: Matrine inhibits
the growth of retinoblastoma cells (SO-Rb50) by decreasing
proliferation and inducing apoptosis in a mitochondrial pathway.
Mol Biol Rep. 41:3475–3480. 2014.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Zhao B, Li B, Bai S, Shen L, Ren R, Jonas
JB, Xu X, Lu Q and Liu Q: Effects of matrine on proliferation and
apoptosis of cultured retinoblastoma cells. Graefes Arch Clin Exp
Ophthalmol. 250:897–905. 2012.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Yu W, Li B, Ren RJ, Gao F, Li LQ, Liu XC
and Wang Y: The effects of matrine on cell proliferation and
telomerase activity in retinoblastoma cells in vitro. Zhonghua Yan
Ke Za Zhi. 42:594–599. 2006.PubMed/NCBI(In Chinese).
|
|
43
|
Luo SX, Deng WY, Wang XF, Lü HF, Han LL,
Chen BB, Chen XB and Li N: Molecular mechanism of
indirubin-3'-monoxime and Matrine in the reversal of paclitaxel
resistance in NCI-H520/TAX25 cell line. Chin Med J (Engl).
126:925–929. 2013.PubMed/NCBI
|
|
44
|
Liao XZ, Tao LT, Liu JH, Gu YY, Xie J,
Chen Y, Lin MG, Liu TL, Wang DM, Guo HY, et al: Matrine combined
with cisplatin synergistically inhibited urothelial bladder cancer
cells via down-regulating VEGF/PI3K/Akt signaling pathway. Cancer
Cell Int. 17(124)2017.PubMed/NCBI View Article : Google Scholar
|
